Diabetes testing will improve with men when you focuses on the downsides of not getting testing. However, that same approach to getting tested for diabetes won't work as well with him, according to a study.
Rick Berenson is charged with developing the business of one of Northeast Ohio's most promising startups -- Thermalin Diabetes, which is developing new forms of insulin called "insulin analogs." The company is offering diabetes without the insulin side effects: it will last longer and have less cancer risk.
Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.
Type 2 diabetes management is the focus and neurodiagnostics is out for NeuroMetrix. The Massachusetts medical device company said it will no longer support its nerve conduction device, laid off 27 percent of its workforce and eliminated its U.S. direct salesforce. Its next device will detect diabetic neuropathy.
Hygieia's glucose monitoring system would allow diabetics to adjust the amount of glucose they inject without visiting a doctor. The device provides dose-by-dose insulin recommendations based on their body chemistry as well as a blood sample. The product is called the Diabetes Insulin Guidance System, but is often described as a GPS for diabetes, adjusting someone's diabetes goals the way a GPS guides drivers on the road.
An investigational study by Cleveland Clinic researchers has shown that a new type of surgery that involves folding a patient's stomach in on itself and stitching it up holds promise in promoting weight loss. The procedure is called gastric plication, and it's performed with a laparascope and five or six incisions to the abdomen.
The artificial pancreas just got a brain. Medtronic Inc. (NYSE:MDT) said Monday the Food and Drug Administration has approved software that helps manage a patient's diabetes therapy.
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
The Philadelphia-area pharmaceutical company hopes for medical breakthroughs in Type 2 diabetes and hypertension. PhaseBio has embarked on Phase I and Phase II testing of its diabetes treatment, Glymera. Another treatment, Vasomera, focuses on hypertension. The $15 million was part of a total $25 million raised by the former Research Triangle Park/Duke University spinoff.
A small Columbus, Ohio, company is hoping to develop a blood glucose monitor for diabetics who are sick of pricking their skin to check their sugar levels. DIRAmed LLC is one of several companies looking to cash in on what's certain to be an exploding market for products and services that help people better treat and manage diabetes and other cardiovascular diseases.
Case Western Reserve University has received a $12.5 million federal grant to implement programs aimed at reducing childhood obesity.
Diabetics have a problem, and a Columbus, Ohio-area startup thinks its technology has what it takes to solve it. GlucoMetrics is hoping to commercialize a portable blood glucose meter that has an error rate below 1 percent.
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
The artificial pancreas will be the focus of a public workshop put on by the U.S. Food & Drug Administration and the National Institutes of Health. Such a device would be comprised of a "closed-loop system that would dispense insulin based on real-time changes in blood sugar levels," according to the FDA, and would "provide a better quality of life and glucose control for those who require daily insulin administration."
A panel at Cleveland Clinic's Medical Innovations Summit focused on five companies developing innovative obesity-fighting medical devices that have yet to hit the market.
Cleveland's newest rock-star doctor has some new ideas on fighting obesity and improving health that are unconventional, innovative -- and a bit weird. Dr. James Levine calls his ideas "The Cleveland Project," and they add up to an ambitious and far-reaching public health plan.
Startup Thermalin Diabetes Inc. has raised $1.9 million in equity to commercialize new forms of insulin developed at Case Western Reserve University, according to a regulatory filing.
In launching Decade of Discovery, a $250 million-to-$350 million diabetes partnership, the University of Minnesota and Mayo Clinic are opting for an approach that requires the help of virtually everyone with a stake in Minnesota's healthcare economy: hospitals, payers, food manufacturers, device companies, biotech startups.